
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23139769</article-id><article-id pub-id-type="pmc">3489680</article-id><article-id pub-id-type="publisher-id">PONE-D-12-11502</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0048265</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Genetics</subject><subj-group><subject>Cancer Genetics</subject><subject>Cytogenetics</subject><subject>Genetic Mutation</subject><subject>Genetics of Disease</subject><subject>Human Genetics</subject><subject>Molecular Genetics</subject><subject>Population Genetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Biomarker Epidemiology</subject><subject>Cancer Epidemiology</subject><subject>Clinical Epidemiology</subject><subject>Environmental Epidemiology</subject><subject>Genetic Epidemiology</subject><subject>Molecular Epidemiology</subject></subj-group></subj-group><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Risk Factors</subject><subj-group><subject>Environmental Causes of Cancer</subject><subject>Genetic Causes of Cancer</subject><subject>Lifestyle Causes of Cancer</subject></subj-group></subj-group><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Gastrointestinal Tumors</subject></subj-group></subj-group></subj-group><subj-group><subject>Public Health</subject><subj-group><subject>Environmental Health</subject><subject>Preventive Medicine</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>CYP2E1 RsaI/PstI Polymorphism and Gastric Cancer Susceptibility: Meta-Analyses Based on 24 Case-Control Studies</article-title><alt-title alt-title-type="running-head">CYP2E1 RsaI/PstI Polymorphism and Gastric Cancer</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhuo</surname><given-names>Wenlei</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ling</surname><given-names>Junjun</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Zhengtang</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Department of Environmental Hygiene, College of Preventive Medicine, Third Military Medical University, Chongqing, China</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, China</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Department of Otolaryngology, Southwest Hospital, Third Military Medical University, Chongqing, China</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Katoh</surname><given-names>Masaru</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>National Cancer Center, Japan</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>zhuowenlei@yahoo.com.cn</email> (WZ); <email>oncology_bozhu@163.com</email> (BZ)</corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: WZ ZC. Performed the experiments: WZ LZ JL YW. Analyzed the data: JL BZ YW. Contributed reagents/materials/analysis tools: WZ LZ BZ. Wrote the paper: WZ ZC.</p></fn></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>5</day><month>11</month><year>2012</year></pub-date><volume>7</volume><issue>11</issue><elocation-id>e48265</elocation-id><history><date date-type="received"><day>23</day><month>4</month><year>2012</year></date><date date-type="accepted"><day>21</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>&#x000a9; 2012 Zhuo et al</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Zhuo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Previous reports implicate CYP2E1 RsaI/PstI polymorphism as a possible risk factor for several cancers. Published studies on the relationship of CYP2E1 RsaI/PstI polymorphisms with the susceptibility to gastric cancer are controversial. This study aimed to determine this relationship accurately.</p></sec><sec><title>Methods</title><p>Meta-analyses that assessed the association of CYP2E1 RsaI/PstI variations with gastric cancer were conducted. Subgroup analyses on ethnicity, smoking status, alcohol consumption, and source of controls were also performed. Eligible studies up to Mar 2012 were identified.</p></sec><sec><title>Results</title><p>After rigorous searching and screening, 24 case-control studies comprising 3022 cases and 4635 controls were selected for analysis. The overall data failed to indicate the significant associations of CYP2E1 RsaI/PstI polymorphisms with the gastric cancer risk [c2 vs. c1: odds ratio (OR)&#x0200a;=&#x0200a;1.06; 95% confidence interval (CI)&#x0200a;=&#x0200a;0.88&#x02013;1.28; c2c2 vs. c1c1: OR&#x0200a;=&#x0200a;1.23; 95% CI&#x0200a;=&#x0200a;0.78&#x02013;1.92; c2c2+c1c2 vs. c1c1: OR&#x0200a;=&#x0200a;0.93; 95% CI&#x0200a;=&#x0200a;0.79&#x02013;1.10]. Similar results were observed in the subgroup analyses on ethnicity, drinking status, and source of controls. However, in the subgroup analysis on smoking status, a borderline increase in cancer risk was found among long-term smokers (c2c2+c1c2 vs. c1c1: OR&#x0200a;=&#x0200a;1.39; 95% CI&#x0200a;=&#x0200a;1.00&#x02013;1.92).</p></sec><sec><title>Conclusion</title><p>CYP2E1 RsaI/PstI polymorphisms may modify the susceptibility to gastric cancer among individuals who have a smoking history. Large and well-designed studies are needed to confirm this conclusion.</p></sec></abstract><funding-group><funding-statement>The authors have no support or funding to report.</funding-statement></funding-group><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Gastric cancer is one of the most common cancers in the world, accounting for 8% of the total cancer cases and resulting in 10% of the total deaths. Over 70% of new cases and deaths occur in developing countries <xref rid="pone.0048265-Jemal1" ref-type="bibr">[1]</xref>. The mechanisms of gastric carcinogenesis are still unknown. Previous epidemiological investigations indicate that smoking, drinking, and <italic>Helicobacter pylori</italic> infection may be risk factors for gastric cancer <xref rid="pone.0048265-Rathbone1" ref-type="bibr">[2]</xref>, <xref rid="pone.0048265-Moy1" ref-type="bibr">[3]</xref>. Nevertheless, only a small proportion of the people exposed to these environmental factors eventually develop gastric cancer, indicating that host genetic factors may have critical functions in gastric carcinogenesis. Therefore, the interactions of genetic factors with environmental factors may contribute to increased gastric carcinoma susceptibility <xref rid="pone.0048265-LopezCarrillo1" ref-type="bibr">[4]</xref>.</p><p>Only a few gene polymorphisms associated with gastric cancer risk have been identified. Metabolizing enzymes are involved in the bioactivation and detoxification of xenobiotics. Cytochrome P4502E1 (CYP2E1), a member of the cytochrome P450 superfamily, is an ethanol-inducible enzyme that metabolically activates various carcinogens, such as benzene, vinyl chloride, and N-dimethylnitrosamines <xref rid="pone.0048265-Bellec1" ref-type="bibr">[5]</xref>, <xref rid="pone.0048265-Guengerich1" ref-type="bibr">[6]</xref>. The activation of nitrosamines is believed to be related to the development of various cancers <xref rid="pone.0048265-Schuller1" ref-type="bibr">[7]</xref>. Several single nucleotide polymorphisms in CYP2E1 gene have been identified. RsaI/PstI polymorphisms, which are in complete linkage disequilibrium, in the 5&#x02032;-flanking promoter region of CYP2E1 are considered to affect the transcriptional activation of CYP2E1 gene <xref rid="pone.0048265-Hayashi1" ref-type="bibr">[8]</xref>. The polymorphisms result in three genotypes, namely, wild-type homozygous (c1c1), heterozygous (c1c2), and variant homozygous (c2c2) genotypes.</p><p>Numerous studies on the possible association of CYP2E1 RsaI/PstI polymorphisms with gastric cancer risk have been conducted. However, the results are controversial. Whether CYP2E1 RsaI/PstI genetic variations can elevate the gastric cancer risk remains uncertain. Thus, in this study, we conducted a quantitative meta-analysis that included published data up to March 2012. This coverage increased the statistical power to determine accurately the relationship between CYP2E1 RsaI/PstI polymorphisms and gastric cancer risk.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>1 Literature Search Strategy</title><p>We carried out searches in Medline, EMBASE, OVID, Sciencedirect, and Chinese National Knowledge Infrastructure (CNKI) without a language limitation, covering all papers published up to Mar 2012. The following keywords were used: <italic>Cytochrome P4502E1</italic>, <italic>CYP2E1</italic>, <italic>gastric</italic>, <italic>neoplasm</italic>, <italic>cancer</italic>, <italic>variation</italic>, and <italic>polymorphism</italic>. All searched studies were retrieved and the bibliographies were further checked for other relevant publications. Review articles and the bibliographies of other relevant studies identified were hand searched to identify additional eligible studies.</p><fig id="pone-0048265-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.g001</object-id><label>Figure 1</label><caption><title>The flow diagram of included/excluded studies.</title></caption><graphic xlink:href="pone.0048265.g001"/></fig><table-wrap id="pone-0048265-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.t001</object-id><label>Table 1</label><caption><title>Characteristics of studies included in the meta-analysis.</title></caption><alternatives><graphic id="pone-0048265-t001-1" xlink:href="pone.0048265.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">First Author</td><td align="left" rowspan="1" colspan="1">Publication Year</td><td align="left" rowspan="1" colspan="1">Number of Cases (male/female)</td><td align="left" rowspan="1" colspan="1">Number of Controls (male/female)</td><td align="left" rowspan="1" colspan="1">Type of controls</td><td align="left" rowspan="1" colspan="1">Median (or mean) age, (range) year (Cases/Controls)</td><td align="left" rowspan="1" colspan="1">Racial decent</td><td align="left" rowspan="1" colspan="1">Country</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Kato</td><td align="left" rowspan="1" colspan="1">1995</td><td align="left" rowspan="1" colspan="1">150 (NA/NA)</td><td align="left" rowspan="1" colspan="1">203 (NA/NA)</td><td align="left" rowspan="1" colspan="1">Non-cancer patients with gastric disease (HB)</td><td align="left" rowspan="1" colspan="1">NA/NA</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Japan</td></tr><tr><td align="left" rowspan="1" colspan="1">Kato</td><td align="left" rowspan="1" colspan="1">1996</td><td align="left" rowspan="1" colspan="1">82 (47/35)</td><td align="left" rowspan="1" colspan="1">151 (83/68)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (age-, gender-matched; HB)</td><td align="left" rowspan="1" colspan="1">61.8(33&#x02013;84)/60.0(32&#x02013;81)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Japan</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang</td><td align="left" rowspan="1" colspan="1">1998</td><td align="left" rowspan="1" colspan="1">83 (50/33)</td><td align="left" rowspan="1" colspan="1">83 (50/33)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-, sex-matched; PB)</td><td align="left" rowspan="1" colspan="1">59.6(NA)/56.7(NA)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Nishimoto (Japanese)</td><td align="left" rowspan="1" colspan="1">2000</td><td align="left" rowspan="1" colspan="1">96 (60/36)</td><td align="left" rowspan="1" colspan="1">192 (120/72)</td><td align="left" rowspan="1" colspan="1">101 inpatients, 11 outpatients, 80 healthy volunteers (age-, gender-, ethnicity-, trimester of hospital admission-matched; HB)</td><td align="left" rowspan="1" colspan="1">65(37&#x02013;89)/65(NA)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Brazil</td></tr><tr><td align="left" rowspan="1" colspan="1">Cai</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">91 (77/14)</td><td align="left" rowspan="1" colspan="1">94 (82/12)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-, sex-matched; PB)</td><td align="left" rowspan="1" colspan="1">58.4(32&#x02013;78)/58.2(34&#x02013;79)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Qian</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">306 (224/82)</td><td align="left" rowspan="1" colspan="1">164 (118/46)</td><td align="left" rowspan="1" colspan="1">Healthy controls (PB)</td><td align="left" rowspan="1" colspan="1">61.54(37&#x02013;82)/61.46(32&#x02013;87)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">98 (75/23)</td><td align="left" rowspan="1" colspan="1">196 (131/65)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-, sex-, ethnicity-matched; PB)</td><td align="left" rowspan="1" colspan="1">NA(40&#x02013;81)/NA(40&#x02013;81)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Ye</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">56 (42/14)</td><td align="left" rowspan="1" colspan="1">56 (39/17)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-, sex-matched; PB)</td><td align="left" rowspan="1" colspan="1">57.6(22&#x02013;79)/58.0(26&#x02013;86)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Tsukino</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">120 (82/38)</td><td align="left" rowspan="1" colspan="1">158 (109/49)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-, gender-matched; PB)</td><td align="left" rowspan="1" colspan="1">61.8(NA)/61.9(NA)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Japan</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">356 (218/138)</td><td align="left" rowspan="1" colspan="1">278 (156/122)</td><td align="left" rowspan="1" colspan="1">Healthy controls (PB)</td><td align="left" rowspan="1" colspan="1">62.0(25&#x02013;87)/61.6(22&#x02013;86)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Zheng</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">92 (74/18)</td><td align="left" rowspan="1" colspan="1">92 (74/18)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-matched; PB)</td><td align="left" rowspan="1" colspan="1">53.2(33&#x02013;67)/53.5(35&#x02013;68)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Park</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">120 (77/43)</td><td align="left" rowspan="1" colspan="1">145 (89/56)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (age-, sex-matched; HB)</td><td align="left" rowspan="1" colspan="1">54.6(NA)/55.1(NA)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Korea</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhou</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">145 (113/32)</td><td align="left" rowspan="1" colspan="1">229 (155/74)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-matched; PB)</td><td align="left" rowspan="1" colspan="1">NA/NA</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Suzuki</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">146 (97/49)</td><td align="left" rowspan="1" colspan="1">177 (120/57)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (age-matched; HB)</td><td align="left" rowspan="1" colspan="1">62.4(30&#x02013;84)/66.6(20&#x02013;93)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Japan</td></tr><tr><td align="left" rowspan="1" colspan="1">Colombo</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">100 (73/27)</td><td align="left" rowspan="1" colspan="1">150 (90/60)</td><td align="left" rowspan="1" colspan="1">Healthy control (age-, gender, ethnicity-matched; PB)</td><td align="left" rowspan="1" colspan="1">60(28&#x02013;93)/54(20&#x02013;93)</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Brazil</td></tr><tr><td align="left" rowspan="1" colspan="1">Gonzalez</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">31 (25/6)</td><td align="left" rowspan="1" colspan="1">51 (33/18)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (HB)</td><td align="left" rowspan="1" colspan="1">60.71(32&#x02013;78)/51.73(18&#x02013;76)</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Costa Rica</td></tr><tr><td align="left" rowspan="1" colspan="1">Nan</td><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">110 (70/40)</td><td align="left" rowspan="1" colspan="1">220 (140/80)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (age-, sex-matched; HB)</td><td align="left" rowspan="1" colspan="1">59.81(NA)/59.6(NA)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Korea</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang</td><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">48 (31/17)</td><td align="left" rowspan="1" colspan="1">48 (28/20)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (HB)</td><td align="left" rowspan="1" colspan="1">NA(50&#x02013;70)/NA(55&#x02013;72)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Agudo</td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">243 (NA/NA)</td><td align="left" rowspan="1" colspan="1">946 (NA/NA)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (age-, gender-, center-, blood collection date-matched; HB)</td><td align="left" rowspan="1" colspan="1">NA/NA</td><td align="left" rowspan="1" colspan="1">Caucasian</td><td align="left" rowspan="1" colspan="1">Ten European countries</td></tr><tr><td align="left" rowspan="1" colspan="1">Boccia</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">107 (56/51)</td><td align="left" rowspan="1" colspan="1">254 (141/113)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (age-, gender-matched; HB)</td><td align="left" rowspan="1" colspan="1">66.4(NA)/64.0(NA)</td><td align="left" rowspan="1" colspan="1">Caucasian</td><td align="left" rowspan="1" colspan="1">Italy</td></tr><tr><td align="left" rowspan="1" colspan="1">Li</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">41 (26/15)</td><td align="left" rowspan="1" colspan="1">41 (24/17)</td><td align="left" rowspan="1" colspan="1">Healthy controls (age-, sex-matched; PB)</td><td align="left" rowspan="1" colspan="1">52.8(40&#x02013;71)/56.6(42&#x02013;71)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">China</td></tr><tr><td align="left" rowspan="1" colspan="1">Malik</td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">108 (90/18)</td><td align="left" rowspan="1" colspan="1">195 (139/56)</td><td align="left" rowspan="1" colspan="1">Healthy control (age-matched; PB)</td><td align="left" rowspan="1" colspan="1">55.91(NA)/57.98(NA)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">India</td></tr><tr><td align="left" rowspan="1" colspan="1">Darazy</td><td align="left" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1">13 (NA/NA)</td><td align="left" rowspan="1" colspan="1">70 (49/21)</td><td align="left" rowspan="1" colspan="1">Healthy control (age-, sex-matched; PB)</td><td align="left" rowspan="1" colspan="1">60.3(NA)/62.8(NA)</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Egypt</td></tr><tr><td align="left" rowspan="1" colspan="1">Kato</td><td align="left" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1">464 (310/NA)</td><td align="left" rowspan="1" colspan="1">553 (322/231)</td><td align="left" rowspan="1" colspan="1">Non-cancer controls (age-, sex-matched; HB)</td><td align="left" rowspan="1" colspan="1">63.0(NA)/51.4(NA)</td><td align="left" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">Japan</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p>NA: not available;</p></fn><fn id="nt102"><p>PB: population-based;</p></fn><fn id="nt103"><p>HB: hospital-based.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2b"><title>2 Inclusion Criteria</title><p>The following criteria were used for the literature selection. First, the study should concern the association of CYP2E1 RsaI/PstI polymorphisms with gastric cancer risk. Second, the study must be observational (case-control or cohort). Third, the study must indicate the sample size, odds ratios (ORs), and their 95% confidence intervals (CIs), as well as the genetic distribution or the information that can help infer the results. After rigorous searching, we reviewed all papers based on the above criteria for further analysis.</p><table-wrap id="pone-0048265-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.t002</object-id><label>Table 2</label><caption><title>Distribution of CYP2E1 RsaI/PstI genotype among gastric cancer cases and controls included in the meta-analysis.</title></caption><alternatives><graphic id="pone-0048265-t002-2" xlink:href="pone.0048265.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">First Author</td><td align="left" rowspan="1" colspan="1">year</td><td align="left" rowspan="1" colspan="1">Genotyping method</td><td colspan="3" align="left" rowspan="1">Cases</td><td colspan="3" align="left" rowspan="1">Controls</td><td colspan="2" align="left" rowspan="1">HWE (control)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c2c2</td><td align="left" rowspan="1" colspan="1">c1c2</td><td align="left" rowspan="1" colspan="1">c1c1</td><td align="left" rowspan="1" colspan="1">c2c2</td><td align="left" rowspan="1" colspan="1">c1c2</td><td align="left" rowspan="1" colspan="1">c1c1</td><td align="left" rowspan="1" colspan="1">Chi-squre</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Kato</td><td align="left" rowspan="1" colspan="1">1995</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">120</td><td align="left" rowspan="1" colspan="1">0.867</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Kato</td><td align="left" rowspan="1" colspan="1">1996</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">29 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">61 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">87</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang</td><td align="left" rowspan="1" colspan="1">1998</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">0.025</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Nishimoto (Japanese)</td><td align="left" rowspan="1" colspan="1">2000</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">2.061</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Cai</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">0.243</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Qian</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">68</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">1.276</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">121</td><td align="left" rowspan="1" colspan="1">1.641</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Ye</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">0.017</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Tsukino</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">0.317</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">215</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">199</td><td align="left" rowspan="1" colspan="1">0.840</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Zheng</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">31 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">47 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Park</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">80</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">1.235</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhou</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">85</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">75</td><td align="left" rowspan="1" colspan="1">140</td><td align="left" rowspan="1" colspan="1">0.840</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Suzuki</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">38 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">107</td><td align="left" rowspan="1" colspan="1">65 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">112</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Colombo</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">89</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">134</td><td align="left" rowspan="1" colspan="1">0.476</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Gonzalez</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">1.442</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Nan</td><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">39 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">88 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">129</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang</td><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">0.892</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Agudo</td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">226</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">880</td><td align="left" rowspan="1" colspan="1">0.676</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Boccia</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">5 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">102</td><td align="left" rowspan="1" colspan="1">20 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">234</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Li</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">1.328</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Malik</td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">177</td><td align="left" rowspan="1" colspan="1">0.689</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Darazy</td><td align="left" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">0.061</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Kato</td><td align="left" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1">PCR-RFLP</td><td align="left" rowspan="1" colspan="1">186 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">280</td><td align="left" rowspan="1" colspan="1">213 (a)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">340</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><p>(a): c2c2+ c1c2.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0048265-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.t003</object-id><label>Table 3</label><caption><title>Distribution of CYP2E1 RsaI/PstI genotype among ever-smokers and never-smokers bearing gastric cancers in the meta-analysis.</title></caption><alternatives><graphic id="pone-0048265-t003-3" xlink:href="pone.0048265.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">First Author</td><td align="left" rowspan="1" colspan="1">year</td><td colspan="2" align="left" rowspan="1">Cases</td><td colspan="2" align="left" rowspan="1">Controls</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c2c2+c1c2</td><td align="left" rowspan="1" colspan="1">c1c1</td><td align="left" rowspan="1" colspan="1">c2c2+c1c2</td><td align="left" rowspan="1" colspan="1">c1c1</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ever smoking</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cai</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">75</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhou</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">83</td></tr><tr><td align="left" rowspan="1" colspan="1">Agudo</td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">151</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">503</td></tr><tr><td align="left" rowspan="1" colspan="1">Boccia</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">99</td></tr><tr><td align="left" rowspan="1" colspan="1">Never smoking</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cai</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">48</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">44</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhou</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">54</td></tr><tr><td align="left" rowspan="1" colspan="1">Agudo</td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">79</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">403</td></tr><tr><td align="left" rowspan="1" colspan="1">Boccia</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">135</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone-0048265-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.t004</object-id><label>Table 4</label><caption><title>Distribution of CYP2E1 RsaI/PstI genotype among ever-drinkers and never-drinkers bearing gastric cancers in the meta-analysis.</title></caption><alternatives><graphic id="pone-0048265-t004-4" xlink:href="pone.0048265.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">First Author</td><td align="left" rowspan="1" colspan="1">year</td><td colspan="2" align="left" rowspan="1">Cases</td><td colspan="2" align="left" rowspan="1">Controls</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c2c2+c1c2</td><td align="left" rowspan="1" colspan="1">c1c1</td><td align="left" rowspan="1" colspan="1">c2c2+c1c2</td><td align="left" rowspan="1" colspan="1">c1c1</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ever drinking</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cai</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhou</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">33</td></tr><tr><td align="left" rowspan="1" colspan="1">Suzuki</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">32</td></tr><tr><td align="left" rowspan="1" colspan="1">Boccia</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">68</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">123</td></tr><tr><td align="left" rowspan="1" colspan="1">Never drinking</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cai</td><td align="left" rowspan="1" colspan="1">2001</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">51</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao</td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">108</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhou</td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">107</td></tr><tr><td align="left" rowspan="1" colspan="1">Suzuki</td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">51</td></tr><tr><td align="left" rowspan="1" colspan="1">Boccia</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">111</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="s2c"><title>3 Data Extraction</title><p>Data were carefully extracted from all eligible publications by two of the authors <bold>(Zhuo and Zhang)</bold> independently in accordance with the aforementioned inclusion criteria. For conflicting evaluations, an agreement was reached after a discussion. When a consensus cannot be reached, another author was to be consulted to resolve the dispute, and then a final decision was made based on a majority of votes. The extracted information was inputted into a database.</p></sec><sec id="s2d"><title>4 Statistical Analysis</title><p>The ORs of CYP2E1 RsaI/PstI polymorphisms and gastric cancer risk were estimated for each study. The pooled ORs were determined for an allelic contrast model (c2 allele vs. c1 allele), a homozygote comparison model (c2c2 vs. c1c1), and a dominant model (c2c2+c1c2 vs. c1c1). To detect any possible sample size bias, the OR and its 95% CI for each study were plotted against the number of participants. The <italic>I</italic>-squared value was used as an index for the heterogeneity test <xref rid="pone.0048265-Higgins1" ref-type="bibr">[9]</xref>, with values less than 25% indicating low, 25% to 50% indicating moderate, and greater than 50% indicating high heterogeneity. A chi-squared-based Q-statistic test was also performed to assess heterogeneity. If the <italic>P</italic> value for the Q-test was more than 0.1, ORs were pooled according to the fixed-effect model (Mantel-Haenszel) <xref rid="pone.0048265-Mantel1" ref-type="bibr">[10]</xref>; otherwise, the random-effect model (DerSimonian and Laird) was used <xref rid="pone.0048265-DerSimonian1" ref-type="bibr">[11]</xref>. The significance of the pooled ORs was determined by the Z-test. The Hardy-Weinberg equilibrium (HWE) was assessed by Fisher&#x02019;s exact test. Publication bias was assessed by visual inspection of funnel plots <xref rid="pone.0048265-Munafo1" ref-type="bibr">[12]</xref>
<bold>,</bold> in which the standard error of log (OR) of each study was plotted against its log (OR). An asymmetric plot indicated possible publication bias. The symmetry of the funnel plot was further evaluated by Egger&#x02019;s linear regression test <xref rid="pone.0048265-Egger1" ref-type="bibr">[13]</xref>. Statistical analysis was performed using the program STATA 11.0 software (Stata Corporation, Texas, USA).</p><table-wrap id="pone-0048265-t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.t005</object-id><label>Table 5</label><caption><title>Main results of the pooled data in the meta-analysis.</title></caption><alternatives><graphic id="pone-0048265-t005-5" xlink:href="pone.0048265.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">No. (cases/controls)</td><td colspan="8" align="left" rowspan="1">c2 vs c1</td><td colspan="5" align="left" rowspan="1">c2c2 vs c1c1</td><td colspan="4" align="left" rowspan="1">(c2c2+c1c2) vs c1c1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1">OR (95%CI)</td><td colspan="2" align="left" rowspan="1">P</td><td colspan="2" align="left" rowspan="1">P (Q-test)</td><td colspan="2" align="left" rowspan="1">
<italic>I</italic>
<sup>2</sup>
</td><td colspan="2" align="left" rowspan="1">OR (95%CI)</td><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">P (Q-test)</td><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sup>2</sup>
</td><td align="left" rowspan="1" colspan="1">OR (95%CI)</td><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">P (Q-test)</td><td align="left" rowspan="1" colspan="1">
<italic>I</italic>
<sup>2</sup>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total</td><td colspan="3" align="left" rowspan="1">3022/4635</td><td colspan="2" align="left" rowspan="1">1.06 (0.88&#x02013;1.28)</td><td colspan="2" align="left" rowspan="1">0.539</td><td colspan="2" align="left" rowspan="1">0.001</td><td colspan="2" align="left" rowspan="1">59.0%</td><td colspan="2" align="left" rowspan="1">1.23 (0.78&#x02013;1.92)</td><td align="left" rowspan="1" colspan="1">0.370</td><td align="left" rowspan="1" colspan="1">0.034</td><td align="left" rowspan="1" colspan="1">43.2%</td><td align="left" rowspan="1" colspan="1">0.93 (0.79&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1">0.413</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">52.6%</td></tr><tr><td colspan="6" align="left" rowspan="1">Ethnicity</td><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Asian</td><td colspan="3" align="left" rowspan="1">2512/3210</td><td align="left" rowspan="1" colspan="1">1.03 (0.83&#x02013;1.28)</td><td colspan="3" align="left" rowspan="1">0.770</td><td colspan="2" align="left" rowspan="1">0.001</td><td colspan="2" align="left" rowspan="1">68.0%</td><td colspan="2" align="left" rowspan="1">1.18 (0.74&#x02013;1.88)</td><td align="left" rowspan="1" colspan="1">0.489</td><td align="left" rowspan="1" colspan="1">0.023</td><td align="left" rowspan="1" colspan="1">48.2%</td><td align="left" rowspan="1" colspan="1">0.92 (0.76&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">0.363</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">61.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">Caucasian</td><td colspan="3" align="left" rowspan="1">346/1174</td><td align="left" rowspan="1" colspan="1">1.23 (0.65&#x02013;2.31)</td><td colspan="3" align="left" rowspan="1">0.526</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">1.30 (0.05&#x02013;31.91)</td><td align="left" rowspan="1" colspan="1">0.874</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">0.94 (0.44&#x02013;2.00)</td><td align="left" rowspan="1" colspan="1">0.872</td><td align="left" rowspan="1" colspan="1">0.192</td><td align="left" rowspan="1" colspan="1">41.1%</td></tr><tr><td align="left" rowspan="1" colspan="1">Mixed</td><td colspan="3" align="left" rowspan="1">164/251</td><td align="left" rowspan="1" colspan="1">1.25 (0.73&#x02013;2.15)</td><td colspan="3" align="left" rowspan="1">0.416</td><td colspan="2" align="left" rowspan="1">0.802</td><td colspan="2" align="left" rowspan="1">0.0%</td><td colspan="2" align="left" rowspan="1">7.16 (0.38&#x02013;136.50)</td><td align="left" rowspan="1" colspan="1">0.191</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1.11 (0.62&#x02013;2.00)</td><td align="left" rowspan="1" colspan="1">0.729</td><td align="left" rowspan="1" colspan="1">0.963</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td colspan="6" align="left" rowspan="1">Sourceof controls</td><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HB</td><td colspan="2" align="left" rowspan="1">1577/2829</td><td colspan="2" align="left" rowspan="1">0.95 (0.74&#x02013;1.21)</td><td colspan="2" align="left" rowspan="1">0.653</td><td colspan="2" align="left" rowspan="1">0.262</td><td colspan="2" align="left" rowspan="1">22.8%</td><td colspan="2" align="left" rowspan="1">0.92 (0.37&#x02013;2.33)</td><td colspan="2" align="left" rowspan="1">0.868</td><td align="left" rowspan="1" colspan="1">0.199</td><td align="left" rowspan="1" colspan="1">31.5%</td><td align="left" rowspan="1" colspan="1">0.89 (0.76&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1">0.153</td><td align="left" rowspan="1" colspan="1">0.361</td><td align="left" rowspan="1" colspan="1">8.7%</td></tr><tr><td align="left" rowspan="1" colspan="1">PB</td><td colspan="2" align="left" rowspan="1">1445/1806</td><td colspan="2" align="left" rowspan="1">1.12 (0.87&#x02013;1.43)</td><td colspan="2" align="left" rowspan="1">0.375</td><td colspan="2" align="left" rowspan="1">0.001</td><td colspan="2" align="left" rowspan="1">65.7%</td><td colspan="2" align="left" rowspan="1">1.36 (0.81&#x02013;2.27)</td><td colspan="2" align="left" rowspan="1">0.248</td><td align="left" rowspan="1" colspan="1">0.041</td><td align="left" rowspan="1" colspan="1">48.7%</td><td align="left" rowspan="1" colspan="1">1.00 (0.75&#x02013;1.33)</td><td align="left" rowspan="1" colspan="1">0.995</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">66.0%</td></tr><tr><td colspan="4" align="left" rowspan="1">Smokingstatus</td><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="2" align="left" rowspan="1">Ever smoking</td><td colspan="2" align="left" rowspan="1">456/898</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.39 (1.00&#x02013;1.92)</td><td align="left" rowspan="1" colspan="1">0.049</td><td align="left" rowspan="1" colspan="1">0.481</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td colspan="2" align="left" rowspan="1">Never smoking</td><td colspan="2" align="left" rowspan="1">227/811</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.90 (0.58&#x02013;1.39)</td><td align="left" rowspan="1" colspan="1">0.635</td><td align="left" rowspan="1" colspan="1">0.498</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td colspan="4" align="left" rowspan="1">Drinkingstatus</td><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td colspan="2" align="left" rowspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="2" align="left" rowspan="1">Ever drinking</td><td colspan="2" align="left" rowspan="1">259/283</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.02 (0.67&#x02013;1.56)</td><td align="left" rowspan="1" colspan="1">0.934</td><td align="left" rowspan="1" colspan="1">0.933</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td colspan="2" align="left" rowspan="1">Never drinking</td><td colspan="2" align="left" rowspan="1">312/619</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td colspan="2" align="left" rowspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.03 (0.76&#x02013;1.39)</td><td align="left" rowspan="1" colspan="1">0.860</td><td align="left" rowspan="1" colspan="1">0.169</td><td align="left" rowspan="1" colspan="1">37.8%</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt105"><p>PB: population-based;</p></fn><fn id="nt106"><p>HB: hospital-based.</p></fn></table-wrap-foot></table-wrap><fig id="pone-0048265-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.g002</object-id><label>Figure 2</label><caption><title>Meta-analysis for the association of gastric cancer risk with CYP2E1 RsaI/PstI polymorphism for the overall data (c2c2+c1c2 vs c1c1).</title></caption><graphic xlink:href="pone.0048265.g002"/></fig></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>1 Study Characteristics</title><p>Relevant publications were retrieved and preliminarily screened. As shown in <xref ref-type="fig" rid="pone-0048265-g001">
<bold>Figure 1</bold>
</xref>, 79 publications were identified, among which 46 irrelevant papers were excluded. Thus, 33 publications were eligible. Two review articles <xref rid="pone.0048265-Agundez1" ref-type="bibr">[14]</xref>, <xref rid="pone.0048265-Gianfagna1" ref-type="bibr">[15]</xref> and one paper on precancerous gastric lesions <xref rid="pone.0048265-You1" ref-type="bibr">[16]</xref> were discarded. Two non-case-control studies <xref rid="pone.0048265-Chen1" ref-type="bibr">[17]</xref>, <xref rid="pone.0048265-Masuda1" ref-type="bibr">[18]</xref> and one study without detailed information <xref rid="pone.0048265-Kato1" ref-type="bibr">[19]</xref> were also excluded. As a result, 27 publications containing 28 case-control studies were selected for data extraction and assessment. Notably, one study conducted in Brazil <xref rid="pone.0048265-Nishimoto1" ref-type="bibr">[20]</xref> involved two separate subgroups, namely, Brazilian and Japanese, respectively. Consequently, the data were extracted and considered as two solitary studies for analysis. Afterwards, three studies <xref rid="pone.0048265-Cai1" ref-type="bibr">[21]</xref>, <xref rid="pone.0048265-Shen1" ref-type="bibr">[22]</xref>, <xref rid="pone.0048265-Zhang1" ref-type="bibr">[23]</xref> and the mentioned Brazilian study <xref rid="pone.0048265-Nishimoto1" ref-type="bibr">[20]</xref> were further discarded because the genetic distributions of the controls significantly deviated from the HWE. Lastly, 24 case-control studies were included in the meta-analyses <xref rid="pone.0048265-Nishimoto1" ref-type="bibr">[20]</xref>, <xref rid="pone.0048265-Kato2" ref-type="bibr">[24]</xref>, <xref rid="pone.0048265-Kato3" ref-type="bibr">[25]</xref>, <xref rid="pone.0048265-Gao1" ref-type="bibr">[26]</xref>, <xref rid="pone.0048265-Cai2" ref-type="bibr">[27]</xref>, <xref rid="pone.0048265-Tsukino1" ref-type="bibr">[28]</xref>, <xref rid="pone.0048265-Wu1" ref-type="bibr">[29]</xref>, <xref rid="pone.0048265-Park1" ref-type="bibr">[30]</xref>, <xref rid="pone.0048265-Suzuki1" ref-type="bibr">[31]</xref>, <xref rid="pone.0048265-Colombo1" ref-type="bibr">[32]</xref>, <xref rid="pone.0048265-Nan1" ref-type="bibr">[33]</xref>, <xref rid="pone.0048265-Agudo1" ref-type="bibr">[34]</xref>, <xref rid="pone.0048265-Gonzalez1" ref-type="bibr">[35]</xref>, <xref rid="pone.0048265-Boccia1" ref-type="bibr">[36]</xref>, <xref rid="pone.0048265-Malik1" ref-type="bibr">[37]</xref>, <xref rid="pone.0048265-Darazy1" ref-type="bibr">[38]</xref>, <xref rid="pone.0048265-Kato4" ref-type="bibr">[39]</xref>, <xref rid="pone.0048265-Ye1" ref-type="bibr">[40]</xref>, <xref rid="pone.0048265-Li1" ref-type="bibr">[41]</xref>, <xref rid="pone.0048265-Zhou1" ref-type="bibr">[42]</xref>, <xref rid="pone.0048265-Wang1" ref-type="bibr">[43]</xref>, <xref rid="pone.0048265-Zheng1" ref-type="bibr">[44]</xref>, <xref rid="pone.0048265-Qian1" ref-type="bibr">[45]</xref>, <xref rid="pone.0048265-Wang2" ref-type="bibr">[46]</xref>.</p><p>Sixteen publications were written in English <xref rid="pone.0048265-Nishimoto1" ref-type="bibr">[20]</xref>, <xref rid="pone.0048265-Kato2" ref-type="bibr">[24]</xref>, <xref rid="pone.0048265-Kato3" ref-type="bibr">[25]</xref>, <xref rid="pone.0048265-Gao1" ref-type="bibr">[26]</xref>, <xref rid="pone.0048265-Cai2" ref-type="bibr">[27]</xref>, <xref rid="pone.0048265-Tsukino1" ref-type="bibr">[28]</xref>, <xref rid="pone.0048265-Wu1" ref-type="bibr">[29]</xref>, <xref rid="pone.0048265-Park1" ref-type="bibr">[30]</xref>, <xref rid="pone.0048265-Suzuki1" ref-type="bibr">[31]</xref>, <xref rid="pone.0048265-Colombo1" ref-type="bibr">[32]</xref>, <xref rid="pone.0048265-Nan1" ref-type="bibr">[33]</xref>, <xref rid="pone.0048265-Agudo1" ref-type="bibr">[34]</xref>, <xref rid="pone.0048265-Boccia1" ref-type="bibr">[36]</xref>, <xref rid="pone.0048265-Malik1" ref-type="bibr">[37]</xref>, <xref rid="pone.0048265-Darazy1" ref-type="bibr">[38]</xref>, <xref rid="pone.0048265-Kato4" ref-type="bibr">[39]</xref>, seven in Chinese <xref rid="pone.0048265-Ye1" ref-type="bibr">[40]</xref>, <xref rid="pone.0048265-Li1" ref-type="bibr">[41]</xref>, <xref rid="pone.0048265-Zhou1" ref-type="bibr">[42]</xref>, <xref rid="pone.0048265-Wang1" ref-type="bibr">[43]</xref>, <xref rid="pone.0048265-Zheng1" ref-type="bibr">[44]</xref>, <xref rid="pone.0048265-Qian1" ref-type="bibr">[45]</xref>, <xref rid="pone.0048265-Wang2" ref-type="bibr">[46]</xref>
<bold>,</bold> and one in Spanish <xref rid="pone.0048265-Gonzalez1" ref-type="bibr">[35]</xref>. The relevant information is listed in <xref ref-type="table" rid="pone-0048265-t001">
<bold>Table 1</bold>
</xref>. The first author, the number and characteristics of cases and controls for each study, and other necessary information are presented.</p><fig id="pone-0048265-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.g003</object-id><label>Figure 3</label><caption><title>Meta-analysis for the association of gastric cancer risk with CYP2E1 RsaI/PstI polymorphism (c2c2+c1c2 vs c1c1; stratified by ethnicity).</title></caption><graphic xlink:href="pone.0048265.g003"/></fig><fig id="pone-0048265-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.g004</object-id><label>Figure 4</label><caption><title>Meta-analysis for the association of gastric cancer risk with CYP2E1 RsaI/PstI polymorphism (c2c2+c1c2 vs c1c1; stratified by source of controls).</title><p>PB: population-based; HB: hospital-based.</p></caption><graphic xlink:href="pone.0048265.g004"/></fig><fig id="pone-0048265-g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.g005</object-id><label>Figure 5</label><caption><title>Meta-analysis for the association of gastric cancer risk with CYP2E1 RsaI/PstI polymorphism stratified by smoking status and alcohol consumption (c2c2+c1c2 vs c1c1; A: smoking status; B: drinking status).</title></caption><graphic xlink:href="pone.0048265.g005"/></fig><fig id="pone-0048265-g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0048265.g006</object-id><label>Figure 6</label><caption><title>Publication bias test for the overall data (c2c2+c1c2 vs c1c1; A: Funnel plot; B: Egger&#x02019;s linear regression test).</title></caption><graphic xlink:href="pone.0048265.g006"/></fig><p>The selected articles included two groups of Caucasians <xref rid="pone.0048265-Agudo1" ref-type="bibr">[34]</xref>, <xref rid="pone.0048265-Boccia1" ref-type="bibr">[36]</xref>, nineteen of Asians <xref rid="pone.0048265-Nishimoto1" ref-type="bibr">[20]</xref>, <xref rid="pone.0048265-Kato2" ref-type="bibr">[24]</xref>, <xref rid="pone.0048265-Kato3" ref-type="bibr">[25]</xref>, <xref rid="pone.0048265-Gao1" ref-type="bibr">[26]</xref>, <xref rid="pone.0048265-Cai2" ref-type="bibr">[27]</xref>, <xref rid="pone.0048265-Tsukino1" ref-type="bibr">[28]</xref>, <xref rid="pone.0048265-Wu1" ref-type="bibr">[29]</xref>, <xref rid="pone.0048265-Park1" ref-type="bibr">[30]</xref>, <xref rid="pone.0048265-Suzuki1" ref-type="bibr">[31]</xref>, <xref rid="pone.0048265-Nan1" ref-type="bibr">[33]</xref>, <xref rid="pone.0048265-Malik1" ref-type="bibr">[37]</xref>, <xref rid="pone.0048265-Kato4" ref-type="bibr">[39]</xref>, <xref rid="pone.0048265-Ye1" ref-type="bibr">[40]</xref>, <xref rid="pone.0048265-Li1" ref-type="bibr">[41]</xref>, <xref rid="pone.0048265-Zhou1" ref-type="bibr">[42]</xref>, <xref rid="pone.0048265-Wang1" ref-type="bibr">[43]</xref>, <xref rid="pone.0048265-Zheng1" ref-type="bibr">[44]</xref>, <xref rid="pone.0048265-Qian1" ref-type="bibr">[45]</xref>, <xref rid="pone.0048265-Wang2" ref-type="bibr">[46]</xref>, and three of mixed ethnicities <xref rid="pone.0048265-Colombo1" ref-type="bibr">[32]</xref>, <xref rid="pone.0048265-Gonzalez1" ref-type="bibr">[35]</xref>, <xref rid="pone.0048265-Darazy1" ref-type="bibr">[38]</xref>.</p><p>The distributions of the CYP2E1 RsaI/PstI genotypes and the genotyping methods of the included studies are presented in <xref ref-type="table" rid="pone-0048265-t002">
<bold>Table 2</bold>
</xref>. The genetic distributions of the control groups in all studies were consistent with the HWE. The genetic distributions of variant c2c2 and c1c2 in six included studies were combined as c2c2+c1c2 <xref rid="pone.0048265-Kato3" ref-type="bibr">[25]</xref>, <xref rid="pone.0048265-Suzuki1" ref-type="bibr">[31]</xref>, <xref rid="pone.0048265-Nan1" ref-type="bibr">[33]</xref>, <xref rid="pone.0048265-Boccia1" ref-type="bibr">[36]</xref>, <xref rid="pone.0048265-Kato4" ref-type="bibr">[39]</xref>, <xref rid="pone.0048265-Zheng1" ref-type="bibr">[44]</xref>. The detailed genetic distributions were not available in the primary literature.</p><p>Data regarding smoking status were obtained from five studies <xref rid="pone.0048265-Gao1" ref-type="bibr">[26]</xref>, <xref rid="pone.0048265-Cai2" ref-type="bibr">[27]</xref>, <xref rid="pone.0048265-Agudo1" ref-type="bibr">[34]</xref>, <xref rid="pone.0048265-Boccia1" ref-type="bibr">[36]</xref>, <xref rid="pone.0048265-Zhou1" ref-type="bibr">[42]</xref>
<bold>(</bold>
<xref ref-type="table" rid="pone-0048265-t003">
<bold>Table 3</bold>
</xref>
<bold>).</bold> As for alcohol consumption, information was extracted from five studies <xref rid="pone.0048265-Gao1" ref-type="bibr">[26]</xref>, <xref rid="pone.0048265-Cai2" ref-type="bibr">[27]</xref>, <xref rid="pone.0048265-Suzuki1" ref-type="bibr">[31]</xref>, <xref rid="pone.0048265-Boccia1" ref-type="bibr">[36]</xref>, <xref rid="pone.0048265-Zhou1" ref-type="bibr">[42]</xref>
<bold>(</bold>
<xref ref-type="table" rid="pone-0048265-t004">
<bold>Table 4</bold>
</xref>
<bold>)</bold>. The studies regarding smoking and drinking only provided the combined genetic distributions (c2c2+c1c2) for variant genotypes rather than the separate genotypes.</p></sec><sec id="s3b"><title>2 Test of Heterogeneity</title><p>As shown in <xref ref-type="table" rid="pone-0048265-t005">
<bold>Table 5</bold>
</xref>, we analyzed the heterogeneity for the allelic contrast (c2 allele vs. c1 allele), homozygote comparison (c2c2 vs. c1c1), and dominant (c2c2+c1c2 vs. c1c1) models, respectively. Studies that provided the combined genetic distributions (c2c2+c1c2) rather than the separate genotypes were included only in the dominant model.</p><p>Marked heterogeneities for the overall data were found in three models (c2 vs. c1: <italic>I</italic>
<sup>2</sup>&#x0200a;=&#x0200a;59.0%; <italic>P</italic>&#x0200a;=&#x0200a;0.001 for Q-test; c2c2 vs. c1c1: <italic>I</italic>
<sup>2</sup>&#x0200a;=&#x0200a;43.2%; <italic>P</italic>&#x0200a;=&#x0200a;0.034 for Q-test; c2c2+c1c2 vs. c1c1: <italic>I</italic>
<sup>2</sup>&#x0200a;=&#x0200a;52.6%; <italic>P</italic>&#x0200a;=&#x0200a;0.001 for Q-test), respectively. However, the subgroup analyses revealed reduced or removed heterogeneities in several subgroups.</p></sec><sec id="s3c"><title>3 Meta-analysis Results</title><p>The main results of the meta-analysis are listed in <xref ref-type="table" rid="pone-0048265-t005">
<bold>Table 5</bold>
</xref>. For the overall data including 3022 cases and 4635 controls, the pooled ORs for the allelic contrast, homozygote comparison, and dominant models were 1.06 (95% CI&#x0200a;=&#x0200a;0.88&#x02013;1.28), 1.23 (95% CI&#x0200a;=&#x0200a;0.78&#x02013;1.92), and 0.93 (95% CI&#x0200a;=&#x0200a;0.79&#x02013;1.10), respectively. These results indicated that CYP2E1 RsaI/PstI variations may have little association with increased or decreased gastric carcinoma susceptibility <bold>(</bold>
<xref ref-type="fig" rid="pone-0048265-g002">
<bold>Figure 2</bold>
</xref>
<bold>)</bold>.</p><p>Considering the potential impact of the confounding factors on the overall results, we further performed subgroup analyses. In the primary literature, only the detailed information on ethnicity, source of controls, smoking and drinking status were sufficient for analysis. Hence, subgroup analyses on these issues were carried out. In the subgroup analysis on ethnicity, no significant association was found in the Asian, Caucasian, or mixed-ethnicity subgroups <bold>(</bold>
<xref ref-type="fig" rid="pone-0048265-g003">
<bold>Figure 3</bold>
</xref>
<bold>)</bold>. Similar results were observed in the subgroup analysis on the source of controls. No increased or decreased risk was found in the hospital- and population-based subgroups <bold>(</bold>
<xref ref-type="fig" rid="pone-0048265-g004">
<bold>Figure 4</bold>
</xref>
<bold>)</bold>. However, in the smoking status subgroups, a borderline increase in cancer risk was found among long-term smokers (OR&#x0200a;=&#x0200a;1.39; 95% CI&#x0200a;=&#x0200a;1.00&#x02013;1.92; <italic>P</italic>&#x0200a;=&#x0200a;0.481 for heterogeneity) but not among non-smokers (OR&#x0200a;=&#x0200a;0.90; 95% CI&#x0200a;=&#x0200a;0.58&#x02013;1.39; <italic>P</italic>&#x0200a;=&#x0200a;0.498 for heterogeneity) <bold>(</bold>
<xref ref-type="fig" rid="pone-0048265-g005">
<bold>Figure 5A</bold>
</xref>
<bold>)</bold>. This finding suggested that the interaction of CYP2E1 polymorphisms with cigarette smoking may slightly increase the gastric carcinoma susceptibility. In the subgroup analysis on alcohol consumption, no association was observed in long-term drinkers or non-drinkers <bold>(</bold>
<xref ref-type="fig" rid="pone-0048265-g005">
<bold>Figure 5B</bold>
</xref>
<bold>).</bold>
</p></sec><sec id="s3d"><title>4 Sensitivity Analysis</title><p>When the effect models were changed, the significance of the overall data for the three models was not statistically altered (data not shown). One-way sensitivity analysis <xref rid="pone.0048265-Tobias1" ref-type="bibr">[47]</xref> was performed to evaluate the stability of the meta-analysis. The statistical significances of the overall results did not change when any single study was omitted (data not shown), indicating the stability of the results.</p></sec><sec id="s3e"><title>5 Bias Diagnostics</title><p>Funnel plots were created to assess possible publication biases. Then, Egger&#x02019;s linear regression tests were performed to assess the symmetries of the plots. The funnel plots appeared to be symmetrical for the overall data <bold>(</bold>
<xref ref-type="fig" rid="pone-0048265-g006">
<bold>Figure 6A</bold>
</xref>
<bold>)</bold>. The results of the Egger&#x02019;s tests also indicated the absence of publication biases <bold>(</bold>
<xref ref-type="fig" rid="pone-0048265-g006">
<bold>Figure 6B</bold>
</xref>
<bold>)</bold> (c2 vs. c1: <italic>t</italic>&#x0200a;=&#x0200a;&#x02212;0.76, <italic>P</italic>&#x0003e;0.05; c2c2 vs. c1c1: <italic>t</italic>&#x0200a;=&#x0200a;&#x02212;0.48, <italic>P</italic>&#x0003e;0.05; c2c2+c1c2 vs. c1c1: <italic>t</italic>&#x0200a;=&#x0200a;&#x02212;1.35, <italic>P</italic>&#x0003e;0.05).</p></sec></sec><sec id="s4"><title>Discussion</title><p>The results showed that CYP2E1 RsaI/PstI polymorphisms may not be correlated with gastric cancer risk. Similar results were found in the subgroups stratified by ethnicity, source of controls, and drinking status. However, in the subgroup analysis on smoking status, the data indicated increased gastric cancer risk in long-term smokers.</p><p>A previous meta-analysis by Boccia et al. <xref rid="pone.0048265-Boccia2" ref-type="bibr">[48]</xref> that included 13 studies prior to year 2006 shows increased gastric cancer risk in Asians. The study also indicated that the interactions of CYP2E1 polymorphism with smoking have little association with gastric cancer risk, in contrast with the present, updated meta-analysis. In the present study, 24 case-control studies involving 3022 cases and 4635 controls were selected. In our primary analyses, 28 case-control studies were selected. However, unstable results for the overall data were found when a sensitivity analysis was performed. Studies whose genetic distributions of controls significantly deviate from the HWE were discarded, considering that the deviation may contribute to bias <xref rid="pone.0048265-Thakkinstian1" ref-type="bibr">[49]</xref>. As expected, stable results were obtained; thus, the credibility and robustness of the results were significantly increased.</p><p>In the subgroup analysis on ethnicity, no significant association was found among Asians, Caucasians, and mixed-ethnicity subgroups, in line with the overall data. Ethnic variations in various genes among different ethnicities may influence gastric cancer susceptibility <xref rid="pone.0048265-Schmidt1" ref-type="bibr">[50]</xref>, <xref rid="pone.0048265-Solus1" ref-type="bibr">[51]</xref>. CYP2E1 variations differ among various ethnicities <xref rid="pone.0048265-Stephens1" ref-type="bibr">[52]</xref>. Thus, CYP2E1 variations may exert different influences on gastric cancer risk among different races. Nevertheless, the data of the present study suggested that the interactions of CYP2E1 RsaI/PstI polymorphisms with ethnic variations may exert little influence on gastric cancer susceptibility. In the present meta-analysis, only two groups of Caucasians were obtained. The results may be due to chance because the limited number of included studies and small sample sizes may give rise to insufficient statistical power to assess a minor effect. Thus, the results should be interpreted with caution. Further investigations with large sample sizes regarding Caucasians are needed to clarify the possible effects of CYP2E1 ethnic variations on gastric cancer risk.</p><p>In the subgroup analysis on the source of controls, significantly increased and decreased gastric cancer risks were not observed in the hospital- and population-based subgroups. Hospital-based controls may not be always truly on behalf of the general population, and may thus underestimate the gastric cancer risk. Therefore, selection bias may exist. Further studies using proper controls with strict matching criteria and large sample sizes are important to reduce such selection biases. However, the data of the present meta-analysis indicated that the selection biases hardly affected the results.</p><p>Smoking is an important established risk factor for gastric cancer. The data of our meta-analysis showed a borderline increase in gastric cancer risk among long-term smokers, in contrast with the results of Boccia et al. <xref rid="pone.0048265-Boccia2" ref-type="bibr">[48]</xref>. Tobacco smoke contains many carcinogens, such as benzopyrene and nitrosamine. These compounds are metabolized by phase-I enzymes including CYP family enzymes, and converted to inactive metabolites by the phase-II enzymes. Previous reports showed that mutant alleles of CYP2E1 have increased transcriptional activity <xref rid="pone.0048265-Nomura1" ref-type="bibr">[53]</xref>. Cigarette smoking can significantly accelerate chlorzoxazone metabolism and enhance the activity of CYP2E1 <xref rid="pone.0048265-Howard1" ref-type="bibr">[54]</xref>, <xref rid="pone.0048265-Benowitz1" ref-type="bibr">[55]</xref>, which may markedly activate a number of carcinogens and thereby result in increased gastric carcinoma risk among long-term smokers. This finding may explain the ability of CYP2E1 polymorphism to increase the cancer risk among long-term smokers. However, only five of the included studies provided sufficient data on smoking status with relatively limited sample sizes. Therefore, the data may underestimate the gastric carcinoma risk and should be interpreted with caution.</p><p>In the subgroup analysis on alcohol consumption, no increased cancer risk was found in long-term drinkers or non-drinkers. CYP2E1 can metabolize and activate many toxicological substrates, including ethanol, to become more reactive, toxic products. Thus, its levels may be elevated after chronic or acute alcohol treatment <xref rid="pone.0048265-Sharma1" ref-type="bibr">[56]</xref>. Therefore, the effect of the interactions between CYP2E1 polymorphism and alcohol consumption on cancer risk should be noted. A recent meta-analysis on hepatocellular cancer suggested that Pst I/Rsa polymorphisms can elevate cancer susceptibility among long-term drinkers <xref rid="pone.0048265-Liu1" ref-type="bibr">[57]</xref>. However, only five studies with limited sample sizes concerning drinking status were included in the present study, with possible biases generated. Further investigations on the effect of the interactions of CYP2E1 polymorphism and drinking on gastric cancer are required to address this controversy.</p><p>In the present meta-analysis, evident between-study heterogeneities for the overall data were observed in the three genetic models; thus, random-effect models were utilized. In the subgroup analyses, removed heterogeneities were also found in the subgroup analysis on Caucasian and mixed ethnicities, as well as on hospital-based controls. Nevertheless, significant heterogeneities were still found in the subgroup analysis on Asians and population-based controls. The data suggested that the heterogeneities may be multifactorial. In addition to the ethnicity and source of controls, other factors such as age, gender, and histological types may also contribute to the heterogeneities.</p><p>Publication bias is an important factor that should be considered in a meta-analysis. We utilized funnel plots to evaluate the possible publication biases. Then, Egger&#x02019;s linear regression test was performed to evaluate their symmetries. The results did not suggest evident biases, which indicated the robustness and credibility of the results.</p><p>Several limitations should be addressed. First, in this meta-analysis, the primary articles only provided data about Caucasians, Asians, and mixed ethnicities. Most of the studies concerned Asians and only two studies concerned Caucasians. Data regarding other ethnicities, such as African, were not available. Second, subgroup analyses on age, gender, histological types, and other factors (such as <italic>H. pylori</italic> infection, an important risk factor for gastric cancer) were not conducted in the present study because relevant data were not available in the primary literature. Third, the sample sizes for a proportion of included studies were relatively small; the matching criteria for the cases and controls were also not strict. Thus, bias may exist. Among the included studies, other genes such as GSTM1 and NAT2 were of concern in several papers. However, the interactions between CYP2E1 RsaI/PstI and other gene polymorphisms can be found in only one of the included studies <xref rid="pone.0048265-Suzuki1" ref-type="bibr">[31]</xref>. Therefore, gene&#x02013;gene interactions cannot be performed as a subgroup analysis because of the insufficient information. Further investigations with larger sample sizes and strict matching criteria in view of more confounding factors are needed to address the possible associations.</p><p>In summary, although the overall data failed to reveal a significant association of CYP2E1 RsaI/PstI polymorphism with gastric cancer risk, the subgroup analyses indicated that the variant c2 allele of CYP2E1 RsaI/PstI may modify gastric carcinoma susceptibility among individuals who have a smoking history.</p></sec></body><back><ref-list><title>References</title><ref id="pone.0048265-Jemal1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Jemal</surname><given-names>A</given-names></name>, <name><surname>Bray</surname><given-names>F</given-names></name> (<year>2011</year>) <collab>Center MM, Ferlay J, Ward E, et al</collab> (<year>2011</year>) <article-title>Global cancer statistics</article-title>. <source>CA Cancer J Clin</source>
<volume>61</volume>: <fpage>69</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">21296855</pub-id></mixed-citation></ref><ref id="pone.0048265-Rathbone1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Rathbone</surname><given-names>M</given-names></name>, <name><surname>Rathbone</surname><given-names>B</given-names></name> (<year>2011</year>) <article-title>Helicobacter pylori and gastric cancer</article-title>. <source>Recent Results Cancer Res</source>
<volume>185</volume>: <fpage>83</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">21822821</pub-id></mixed-citation></ref><ref id="pone.0048265-Moy1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Moy</surname><given-names>KA</given-names></name>, <name><surname>Fan</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>R</given-names></name>, <name><surname>Gao</surname><given-names>YT</given-names></name>, <name><surname>Yu</surname><given-names>MC</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<volume>19</volume>: <fpage>2287</fpage>&#x02013;<lpage>2297</lpage>.<pub-id pub-id-type="pmid">20699372</pub-id></mixed-citation></ref><ref id="pone.0048265-LopezCarrillo1"><label>4</label><mixed-citation publication-type="other">Lopez-Carrillo L, Camargo MC, Schneider BG, Sicinschi LA, Hernandez-Ramirez RU, <etal>et al</etal>.. (2012) Capsaicin consumption, Helicobacter pylori CagA status and IL1B-31C&#x0003e;T genotypes: A host and environment interaction in gastric cancer. Food Chem Toxicol.</mixed-citation></ref><ref id="pone.0048265-Bellec1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Bellec</surname><given-names>G</given-names></name>, <name><surname>Dreano</surname><given-names>Y</given-names></name>, <name><surname>Lozach</surname><given-names>P</given-names></name>, <name><surname>Menez</surname><given-names>JF</given-names></name>, <name><surname>Berthou</surname><given-names>F</given-names></name> (<year>1996</year>) <article-title>Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes</article-title>. <source>Carcinogenesis</source>
<volume>17</volume>: <fpage>2029</fpage>&#x02013;<lpage>2034</lpage>.<pub-id pub-id-type="pmid">8824531</pub-id></mixed-citation></ref><ref id="pone.0048265-Guengerich1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Guengerich</surname><given-names>FP</given-names></name>, <name><surname>Kim</surname><given-names>DH</given-names></name>, <name><surname>Iwasaki</surname><given-names>M</given-names></name> (<year>1991</year>) <article-title>Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects</article-title>. <source>Chem Res Toxicol</source>
<volume>4</volume>: <fpage>168</fpage>&#x02013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">1664256</pub-id></mixed-citation></ref><ref id="pone.0048265-Schuller1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Schuller</surname><given-names>HM</given-names></name> (<year>2007</year>) <article-title>Nitrosamines as nicotinic receptor ligands</article-title>. <source>Life Sci</source>
<volume>80</volume>: <fpage>2274</fpage>&#x02013;<lpage>2280</lpage>.<pub-id pub-id-type="pmid">17459420</pub-id></mixed-citation></ref><ref id="pone.0048265-Hayashi1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Hayashi</surname><given-names>S</given-names></name>, <name><surname>Watanabe</surname><given-names>J</given-names></name>, <name><surname>Kawajiri</surname><given-names>K</given-names></name> (<year>1991</year>) <article-title>Genetic polymorphisms in the 5&#x02032;-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene</article-title>. <source>J Biochem</source>
<volume>110</volume>: <fpage>559</fpage>&#x02013;<lpage>565</lpage>.<pub-id pub-id-type="pmid">1778977</pub-id></mixed-citation></ref><ref id="pone.0048265-Higgins1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Higgins</surname><given-names>JP</given-names></name>, <name><surname>Thompson</surname><given-names>SG</given-names></name>, <name><surname>Deeks</surname><given-names>JJ</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source>
<volume>327</volume>: <fpage>557</fpage>&#x02013;<lpage>560</lpage>.<pub-id pub-id-type="pmid">12958120</pub-id></mixed-citation></ref><ref id="pone.0048265-Mantel1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Mantel</surname><given-names>N</given-names></name>, <name><surname>Haenszel</surname><given-names>W</given-names></name> (<year>1959</year>) <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source>
<volume>22</volume>: <fpage>719</fpage>&#x02013;<lpage>748</lpage>.<pub-id pub-id-type="pmid">13655060</pub-id></mixed-citation></ref><ref id="pone.0048265-DerSimonian1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>DerSimonian</surname><given-names>R</given-names></name>, <name><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source>
<volume>7</volume>: <fpage>177</fpage>&#x02013;<lpage>188</lpage>.<pub-id pub-id-type="pmid">3802833</pub-id></mixed-citation></ref><ref id="pone.0048265-Munafo1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Munafo</surname><given-names>MR</given-names></name>, <name><surname>Clark</surname><given-names>TG</given-names></name>, <name><surname>Flint</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>Assessing publication bias in genetic association studies: evidence from a recent meta-analysis</article-title>. <source>Psychiatry Res</source>
<volume>129</volume>: <fpage>39</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">15572183</pub-id></mixed-citation></ref><ref id="pone.0048265-Egger1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Egger</surname><given-names>M</given-names></name>, <name><surname>Davey Smith</surname><given-names>G</given-names></name>, <name><surname>Schneider</surname><given-names>M</given-names></name>, <name><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>
<volume>315</volume>: <fpage>629</fpage>&#x02013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">9310563</pub-id></mixed-citation></ref><ref id="pone.0048265-Agundez1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Agundez</surname><given-names>JA</given-names></name> (<year>2004</year>) <article-title>Cytochrome P450 gene polymorphism and cancer</article-title>. <source>Curr Drug Metab</source>
<volume>5</volume>: <fpage>211</fpage>&#x02013;<lpage>224</lpage>.<pub-id pub-id-type="pmid">15180491</pub-id></mixed-citation></ref><ref id="pone.0048265-Gianfagna1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Gianfagna</surname><given-names>F</given-names></name>, <name><surname>De Feo</surname><given-names>E</given-names></name>, <name><surname>van Duijn</surname><given-names>CM</given-names></name>, <name><surname>Ricciardi</surname><given-names>G</given-names></name>, <name><surname>Boccia</surname><given-names>S</given-names></name> (<year>2008</year>) <article-title>A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk</article-title>. <source>Curr Genomics</source>
<volume>9</volume>: <fpage>361</fpage>&#x02013;<lpage>374</lpage>.<pub-id pub-id-type="pmid">19506726</pub-id></mixed-citation></ref><ref id="pone.0048265-You1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>You</surname><given-names>WC</given-names></name>, <name><surname>Hong</surname><given-names>JY</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Pan</surname><given-names>KF</given-names></name>, <name><surname>Pee</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<volume>14</volume>: <fpage>451</fpage>&#x02013;<lpage>458</lpage>.<pub-id pub-id-type="pmid">15734972</pub-id></mixed-citation></ref><ref id="pone.0048265-Chen1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>SY</given-names></name>, <name><surname>Liu</surname><given-names>TY</given-names></name>, <name><surname>Shun</surname><given-names>CT</given-names></name>, <name><surname>Wu</surname><given-names>MS</given-names></name>, <name><surname>Lu</surname><given-names>TH</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer</article-title>. <source>Int J Cancer</source>
<volume>108</volume>: <fpage>606</fpage>&#x02013;<lpage>612</lpage>.<pub-id pub-id-type="pmid">14696128</pub-id></mixed-citation></ref><ref id="pone.0048265-Masuda1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Masuda</surname><given-names>G</given-names></name>, <name><surname>Tokunaga</surname><given-names>A</given-names></name>, <name><surname>Shirakawa</surname><given-names>T</given-names></name>, <name><surname>Togashi</surname><given-names>A</given-names></name>, <name><surname>Kiyama</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years</article-title>. <source>Gastric Cancer</source>
<volume>10</volume>: <fpage>98</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">17577619</pub-id></mixed-citation></ref><ref id="pone.0048265-Kato1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Kato</surname><given-names>S</given-names></name>, <name><surname>Onda</surname><given-names>M</given-names></name>, <name><surname>Matsukura</surname><given-names>N</given-names></name>, <name><surname>Tokunaga</surname><given-names>A</given-names></name>, <name><surname>Matsuda</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Helicobacter pylori infection and genetic polymorphisms for cancer-related genes in gastric carcinogenesis</article-title>. <source>Biomed Pharmacother</source>
<volume>51</volume>: <fpage>145</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">9207980</pub-id></mixed-citation></ref><ref id="pone.0048265-Nishimoto1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Nishimoto</surname><given-names>IN</given-names></name>, <name><surname>Hanaoka</surname><given-names>T</given-names></name>, <name><surname>Sugimura</surname><given-names>H</given-names></name>, <name><surname>Nagura</surname><given-names>K</given-names></name>, <name><surname>Ihara</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<volume>9</volume>: <fpage>675</fpage>&#x02013;<lpage>680</lpage>.<pub-id pub-id-type="pmid">10919737</pub-id></mixed-citation></ref><ref id="pone.0048265-Cai1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Cai</surname><given-names>L</given-names></name>, <name><surname>Zheng</surname><given-names>ZL</given-names></name>, <name><surname>Zhang</surname><given-names>ZF</given-names></name> (<year>2005</year>) <article-title>Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer</article-title>. <source>World J Gastroenterol</source>
<volume>11</volume>: <fpage>1867</fpage>&#x02013;<lpage>1871</lpage>.<pub-id pub-id-type="pmid">15793883</pub-id></mixed-citation></ref><ref id="pone.0048265-Shen1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Shen</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Yan</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Fu</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Analysis and estimates of the attributable risk for environmental and genetic risk factors in gastric cancer in a Chinese population</article-title>. <source>J Toxicol Environ Health A</source>
<volume>72</volume>: <fpage>759</fpage>&#x02013;<lpage>766</lpage>.<pub-id pub-id-type="pmid">19492240</pub-id></mixed-citation></ref><ref id="pone.0048265-Zhang1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Shen</surname><given-names>X</given-names></name> (<year>2006</year>) <article-title>Interaction of Polymorphisms of CYP2E1 and Environmental Risk Factors in Gastric Cancer</article-title>. <source>J Environ Health</source>
<volume>23</volume>: <fpage>7</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="pone.0048265-Kato2"><label>24</label><mixed-citation publication-type="other">Kato S, Onda M, Matsukura N, Tokunaga A, Tajiri T, <etal>et al</etal>.. (1995) Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease. Pharmacogenetics 5 Spec No: S141&#x02013;144.</mixed-citation></ref><ref id="pone.0048265-Kato3"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Kato</surname><given-names>S</given-names></name>, <name><surname>Onda</surname><given-names>M</given-names></name>, <name><surname>Matsukura</surname><given-names>N</given-names></name>, <name><surname>Tokunaga</surname><given-names>A</given-names></name>, <name><surname>Matsuda</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study</article-title>. <source>Cancer</source>
<volume>77</volume>: <fpage>1654</fpage>&#x02013;<lpage>1661</lpage>.<pub-id pub-id-type="pmid">8608558</pub-id></mixed-citation></ref><ref id="pone.0048265-Gao1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Gao</surname><given-names>C</given-names></name>, <name><surname>Takezaki</surname><given-names>T</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<volume>11</volume>: <fpage>29</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">11815398</pub-id></mixed-citation></ref><ref id="pone.0048265-Cai2"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Cai</surname><given-names>L</given-names></name>, <name><surname>Yu</surname><given-names>SZ</given-names></name>, <name><surname>Zhan</surname><given-names>ZF</given-names></name> (<year>2001</year>) <article-title>Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province</article-title>. <source>World J Gastroenterol</source>
<volume>7</volume>: <fpage>792</fpage>&#x02013;<lpage>795</lpage>.<pub-id pub-id-type="pmid">11854903</pub-id></mixed-citation></ref><ref id="pone.0048265-Tsukino1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Tsukino</surname><given-names>H</given-names></name>, <name><surname>Kuroda</surname><given-names>Y</given-names></name>, <name><surname>Qiu</surname><given-names>D</given-names></name>, <name><surname>Nakao</surname><given-names>H</given-names></name>, <name><surname>Imai</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma</article-title>. <source>Int J Cancer</source>
<volume>100</volume>: <fpage>425</fpage>&#x02013;<lpage>428</lpage>.<pub-id pub-id-type="pmid">12115524</pub-id></mixed-citation></ref><ref id="pone.0048265-Wu1"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Wu</surname><given-names>MS</given-names></name>, <name><surname>Chen</surname><given-names>CJ</given-names></name>, <name><surname>Lin</surname><given-names>MT</given-names></name>, <name><surname>Wang</surname><given-names>HP</given-names></name>, <name><surname>Shun</surname><given-names>CT</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan</article-title>. <source>Int J Colorectal Dis</source>
<volume>17</volume>: <fpage>338</fpage>&#x02013;<lpage>343</lpage>.<pub-id pub-id-type="pmid">12172927</pub-id></mixed-citation></ref><ref id="pone.0048265-Park1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Park</surname><given-names>GT</given-names></name>, <name><surname>Lee</surname><given-names>OY</given-names></name>, <name><surname>Kwon</surname><given-names>SJ</given-names></name>, <name><surname>Lee</surname><given-names>CG</given-names></name>, <name><surname>Yoon</surname><given-names>BC</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans</article-title>. <source>J Gastroenterol Hepatol</source>
<volume>18</volume>: <fpage>1257</fpage>&#x02013;<lpage>1263</lpage>.<pub-id pub-id-type="pmid">14535982</pub-id></mixed-citation></ref><ref id="pone.0048265-Suzuki1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Suzuki</surname><given-names>S</given-names></name>, <name><surname>Muroishi</surname><given-names>Y</given-names></name>, <name><surname>Nakanishi</surname><given-names>I</given-names></name>, <name><surname>Oda</surname><given-names>Y</given-names></name> (<year>2004</year>) <article-title>Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer</article-title>. <source>J Gastroenterol</source>
<volume>39</volume>: <fpage>220</fpage>&#x02013;<lpage>230</lpage>.<pub-id pub-id-type="pmid">15064998</pub-id></mixed-citation></ref><ref id="pone.0048265-Colombo1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Colombo</surname><given-names>J</given-names></name>, <name><surname>Rossit</surname><given-names>AR</given-names></name>, <name><surname>Caetano</surname><given-names>A</given-names></name>, <name><surname>Borim</surname><given-names>AA</given-names></name>, <name><surname>Wornrath</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population</article-title>. <source>World J Gastroenterol</source>
<volume>10</volume>: <fpage>1240</fpage>&#x02013;<lpage>1245</lpage>.<pub-id pub-id-type="pmid">15112335</pub-id></mixed-citation></ref><ref id="pone.0048265-Nan1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Nan</surname><given-names>HM</given-names></name>, <name><surname>Song</surname><given-names>YJ</given-names></name>, <name><surname>Yun</surname><given-names>HY</given-names></name>, <name><surname>Park</surname><given-names>JS</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name> (<year>2005</year>) <article-title>Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer</article-title>. <source>World J Gastroenterol</source>
<volume>11</volume>: <fpage>3834</fpage>&#x02013;<lpage>3841</lpage>.<pub-id pub-id-type="pmid">15991278</pub-id></mixed-citation></ref><ref id="pone.0048265-Agudo1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Agudo</surname><given-names>A</given-names></name>, <name><surname>Sala</surname><given-names>N</given-names></name>, <name><surname>Pera</surname><given-names>G</given-names></name>, <name><surname>Capella</surname><given-names>G</given-names></name>, <name><surname>Berenguer</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>
<volume>15</volume>: <fpage>1043</fpage>&#x02013;<lpage>1045</lpage>.<pub-id pub-id-type="pmid">16702391</pub-id></mixed-citation></ref><ref id="pone.0048265-Gonzalez1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Gonzalez</surname><given-names>A</given-names></name>, <name><surname>Ramirez</surname><given-names>V</given-names></name>, <name><surname>Cuenca</surname><given-names>P</given-names></name>, <name><surname>Sierra</surname><given-names>R</given-names></name> (<year>2004</year>) <article-title>Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility</article-title>. <source>Rev Biol Trop</source>
<volume>52</volume>: <fpage>591</fpage>&#x02013;<lpage>600</lpage>.<pub-id pub-id-type="pmid">17361553</pub-id></mixed-citation></ref><ref id="pone.0048265-Boccia1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Boccia</surname><given-names>S</given-names></name>, <name><surname>Sayed-Tabatabaei</surname><given-names>FA</given-names></name>, <name><surname>Persiani</surname><given-names>R</given-names></name>, <name><surname>Gianfagna</surname><given-names>F</given-names></name>, <name><surname>Rausei</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population</article-title>. <source>BMC Cancer</source>
<volume>7</volume>: <fpage>206</fpage>.<pub-id pub-id-type="pmid">17996038</pub-id></mixed-citation></ref><ref id="pone.0048265-Malik1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Malik</surname><given-names>MA</given-names></name>, <name><surname>Upadhyay</surname><given-names>R</given-names></name>, <name><surname>Mittal</surname><given-names>RD</given-names></name>, <name><surname>Zargar</surname><given-names>SA</given-names></name>, <name><surname>Modi</surname><given-names>DR</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley</article-title>. <source>J Gastrointest Cancer</source>
<volume>40</volume>: <fpage>26</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">19521675</pub-id></mixed-citation></ref><ref id="pone.0048265-Darazy1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Darazy</surname><given-names>M</given-names></name>, <name><surname>Balbaa</surname><given-names>M</given-names></name>, <name><surname>Mugharbil</surname><given-names>A</given-names></name>, <name><surname>Saeed</surname><given-names>H</given-names></name>, <name><surname>Sidani</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese</article-title>. <source>Genet Test Mol Biomarkers</source>
<volume>15</volume>: <fpage>423</fpage>&#x02013;<lpage>429</lpage>.<pub-id pub-id-type="pmid">21385088</pub-id></mixed-citation></ref><ref id="pone.0048265-Kato4"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Kato</surname><given-names>S</given-names></name>, <name><surname>Naito</surname><given-names>Z</given-names></name>, <name><surname>Matsuda</surname><given-names>N</given-names></name>, <name><surname>Onodera</surname><given-names>H</given-names></name>, <name><surname>Sakurazawa</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Localization of cytochrome P4502E1 enzyme in normal and cancerous gastric mucosa and association with its genetic polymorphism in unoperated and remnant stomach</article-title>. <source>J Nihon Med Sch</source>
<volume>78</volume>: <fpage>224</fpage>&#x02013;<lpage>234</lpage>.</mixed-citation></ref><ref id="pone.0048265-Ye1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Ye</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>X</given-names></name>, <name><surname>Deng</surname><given-names>C</given-names></name> (<year>2002</year>) <article-title>Association between CYE2E1 genotype and genetic susceptibility of gastric cancer</article-title>. <source>J Fourth Mil Med Univ</source>
<volume>23</volume>: <fpage>2265</fpage>&#x02013;<lpage>2267</lpage>.</mixed-citation></ref><ref id="pone.0048265-Li1"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Xu</surname><given-names>L</given-names></name> (<year>2007</year>) <article-title>CYP2E1 polymorphism and gastic cancer susceptibility</article-title>. <source>J Pract Med</source>
<volume>23</volume>: <fpage>3380</fpage>&#x02013;<lpage>3381</lpage>.</mixed-citation></ref><ref id="pone.0048265-Zhou1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Zhou</surname><given-names>J</given-names></name>, <name><surname>Gao</surname><given-names>C</given-names></name>, <name><surname>Takezaki</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Interaction between Polymorphisms in CYP2E1 Rsa I Genotypes and Lifestyle with Risk of Stomach Cancer</article-title>. <source>J Oncol</source>
<volume>9</volume>: <fpage>285</fpage>&#x02013;<lpage>288</lpage>.</mixed-citation></ref><ref id="pone.0048265-Wang1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>W</given-names></name> (<year>2005</year>) <article-title>Effects of genetic polymorphism of cytochrome P4502 E1 on susceptibility to gastric cancer</article-title>. <source>Chin J Public Health</source>
<volume>21</volume>: <fpage>664</fpage>&#x02013;<lpage>665</lpage>.</mixed-citation></ref><ref id="pone.0048265-Zheng1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Zheng</surname><given-names>Q</given-names></name>, <name><surname>Gong</surname><given-names>F</given-names></name>, <name><surname>Xie</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Zheng</surname><given-names>T</given-names></name> (<year>2002</year>) <article-title>Relationship between genetic polymorphisms of cytochrome P450 2E1 and gastric cancer</article-title>. <source>Chin J Dig</source>
<volume>22</volume>: <fpage>144</fpage>&#x02013;<lpage>146</lpage>.</mixed-citation></ref><ref id="pone.0048265-Qian1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Qian</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Shen</surname><given-names>H</given-names></name>, <name><surname>Yu</surname><given-names>R</given-names></name>, <name><surname>Qin</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Cytochrome P4502E1 and the Genetic Susceptibility to Gastric Cancer</article-title>. <source>Chin Prim Health Care</source>
<volume>15</volume>: <fpage>16</fpage>&#x02013;<lpage>18</lpage>.</mixed-citation></ref><ref id="pone.0048265-Wang2"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Hsieh</surname><given-names>L</given-names></name> (<year>1998</year>) <article-title>The relationship between the genotypes of cancer susceptibility genes and the development of gastric cancer</article-title>. <source>Chin J Pub Health</source>
<volume>17</volume>: <fpage>226</fpage>&#x02013;<lpage>241</lpage>.</mixed-citation></ref><ref id="pone.0048265-Tobias1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Tobias</surname><given-names>A</given-names></name> (<year>1999</year>) <article-title>Assessing the influence of a single study in the meta-analysis estimate</article-title>. <source>Stata Techn Bull</source>
<volume>8</volume>: <fpage>15</fpage>&#x02013;<lpage>17</lpage>.</mixed-citation></ref><ref id="pone.0048265-Boccia2"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Boccia</surname><given-names>S</given-names></name>, <name><surname>De Lauretis</surname><given-names>A</given-names></name>, <name><surname>Gianfagna</surname><given-names>F</given-names></name>, <name><surname>van Duijn</surname><given-names>CM</given-names></name>, <name><surname>Ricciardi</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature</article-title>. <source>Carcinogenesis</source>
<volume>28</volume>: <fpage>101</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">16837478</pub-id></mixed-citation></ref><ref id="pone.0048265-Thakkinstian1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Thakkinstian</surname><given-names>A</given-names></name>, <name><surname>McElduff</surname><given-names>P</given-names></name>, <name><surname>D'Este</surname><given-names>C</given-names></name>, <name><surname>Duffy</surname><given-names>D</given-names></name>, <name><surname>Attia</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>A method for meta-analysis of molecular association studies</article-title>. <source>Stat Med</source>
<volume>24</volume>: <fpage>1291</fpage>&#x02013;<lpage>1306</lpage>.<pub-id pub-id-type="pmid">15568190</pub-id></mixed-citation></ref><ref id="pone.0048265-Schmidt1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Schmidt</surname><given-names>HM</given-names></name>, <name><surname>Ha</surname><given-names>DM</given-names></name>, <name><surname>Taylor</surname><given-names>EF</given-names></name>, <name><surname>Kovach</surname><given-names>Z</given-names></name>, <name><surname>Goh</surname><given-names>KL</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Variation in human genetic polymorphisms, their association with Helicobacter pylori acquisition and gastric cancer in a multi-ethnic country</article-title>. <source>J Gastroenterol Hepatol</source>
<volume>26</volume>: <fpage>1725</fpage>&#x02013;<lpage>1732</lpage>.<pub-id pub-id-type="pmid">21649724</pub-id></mixed-citation></ref><ref id="pone.0048265-Solus1"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Solus</surname><given-names>JF</given-names></name>, <name><surname>Arietta</surname><given-names>BJ</given-names></name>, <name><surname>Harris</surname><given-names>JR</given-names></name>, <name><surname>Sexton</surname><given-names>DP</given-names></name>, <name><surname>Steward</surname><given-names>JQ</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population</article-title>. <source>Pharmacogenomics</source>
<volume>5</volume>: <fpage>895</fpage>&#x02013;<lpage>931</lpage>.<pub-id pub-id-type="pmid">15469410</pub-id></mixed-citation></ref><ref id="pone.0048265-Stephens1"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Stephens</surname><given-names>EA</given-names></name>, <name><surname>Taylor</surname><given-names>JA</given-names></name>, <name><surname>Kaplan</surname><given-names>N</given-names></name>, <name><surname>Yang</surname><given-names>CH</given-names></name>, <name><surname>Hsieh</surname><given-names>LL</given-names></name>, <etal>et al</etal> (<year>1994</year>) <article-title>Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese</article-title>. <source>Pharmacogenetics</source>
<volume>4</volume>: <fpage>185</fpage>&#x02013;<lpage>192</lpage>.<pub-id pub-id-type="pmid">7987402</pub-id></mixed-citation></ref><ref id="pone.0048265-Nomura1"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Nomura</surname><given-names>F</given-names></name>, <name><surname>Itoga</surname><given-names>S</given-names></name>, <name><surname>Uchimoto</surname><given-names>T</given-names></name>, <name><surname>Tomonaga</surname><given-names>T</given-names></name>, <name><surname>Nezu</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Transcriptional activity of the tandem repeat polymorphism in the 5&#x02032;-flanking region of the human CYP2E1 gene</article-title>. <source>Alcohol Clin Exp Res</source>
<volume>27</volume>: <fpage>42S</fpage>&#x02013;<lpage>46S</lpage>.<pub-id pub-id-type="pmid">12960506</pub-id></mixed-citation></ref><ref id="pone.0048265-Howard1"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Howard</surname><given-names>LA</given-names></name>, <name><surname>Micu</surname><given-names>AL</given-names></name>, <name><surname>Sellers</surname><given-names>EM</given-names></name>, <name><surname>Tyndale</surname><given-names>RF</given-names></name> (<year>2001</year>) <article-title>Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver</article-title>. <source>J Pharmacol Exp Ther</source>
<volume>299</volume>: <fpage>542</fpage>&#x02013;<lpage>550</lpage>.<pub-id pub-id-type="pmid">11602665</pub-id></mixed-citation></ref><ref id="pone.0048265-Benowitz1"><label>55</label><mixed-citation publication-type="journal">
<collab>Benowitz NL, Peng M, Jacob P, 3rd</collab> (<year>2003</year>) <article-title>Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism</article-title>. <source>Clin Pharmacol Ther</source>
<volume>74</volume>: <fpage>468</fpage>&#x02013;<lpage>474</lpage>.<pub-id pub-id-type="pmid">14586387</pub-id></mixed-citation></ref><ref id="pone.0048265-Sharma1"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Sharma</surname><given-names>A</given-names></name>, <name><surname>Saurabh</surname><given-names>K</given-names></name>, <name><surname>Yadav</surname><given-names>S</given-names></name>, <name><surname>Jain</surname><given-names>SK</given-names></name>, <name><surname>Parmar</surname><given-names>D</given-names></name> (<year>2012</year>) <article-title>Ethanol induced induction of cytochrome P450 2E1 and activation of mitogen activated protein kinases in peripheral blood lymphocytes</article-title>. <source>Xenobiotica</source>
<volume>42</volume>: <fpage>317</fpage>&#x02013;<lpage>326</lpage>.<pub-id pub-id-type="pmid">21999510</pub-id></mixed-citation></ref><ref id="pone.0048265-Liu1"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Pan</surname><given-names>C</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name> (<year>2012</year>) <article-title>CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls</article-title>. <source>Tumour Biol</source>
<volume>33</volume>: <fpage>979</fpage>&#x02013;<lpage>984</lpage>.<pub-id pub-id-type="pmid">22249978</pub-id></mixed-citation></ref></ref-list></back></article>